SEC FORM 4

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Miller Carleton M

(Last)

(First)

(Middle)

C/O VISLINK TECHNOLOGIES, INC.

350 CLARK DRIVE, SUITE 125

(Street)

MT. OLIVE

07828

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Vislink Technologies, Inc. [ VISL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/19/2023

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	12/19/2023		F		30,006⁽¹⁾	D	$4.59	210,079⁽²⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Option to Purchase (Performance-Vested)	$34.2	12/21/2023		D⁽³⁾			12,500	⁽⁴⁾	01/22/2030	Common Stock	12,500	$0	0	D
Option to Purchase (Time-Vested)	$34.2	12/21/2023		D⁽³⁾			17,961	⁽⁵⁾	01/22/2030	Common Stock	17,961	$0	0	D

Explanation of Responses:

1. Reflects the issuance of 30,006 shares of Common Stock, net of shares witheld to pay taxes, upon vesting and delivery to the Reporting Person of the time-based tranche of 14,970 restricted stock units awarded in March 2021 and 23,673 restricted stock units awarded in February 2022.

2. Includes 38,643 shares of Common Stock that have vested pursuant to previously issued restricted stock units; also includes an additional 82,124 shares of Common Stock issuable pursuant to restricted stock units that will potentially vest by December 1, 2026. All such vested and unvested shares were previously reported on a Form 4 at the time of grant.

3. On December 21, 2023, the Reporting Person voluntarily agreed to relinquish a previously issued option to purchase 30,461 shares of Common Stock granted to the Reporting Person on January 22, 2020, which includes 12,500 Performance-Vested Options and 17,961 Time-Vested Options.

4. The Performance-Vested Option would have vested in three equal tranches of 500,000 shares upon the Issuer's attainment, on or before the fifth anniversary of the award date, of specified cumulative EBITDA performance conditions in the Option Agreement dated as of January 22, 2020, subject in each case to the Reporting Person's continued employment by the Issuer on the applicable vesting date. None of these options have vested.

5. The Time-Vested Option would have become exercisable in full by January 22, 2024.

	/s/ Ira Kotel, attorney-in-fact	12/21/2023
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.